NO20075194L - vaksine - Google Patents

vaksine

Info

Publication number
NO20075194L
NO20075194L NO20075194A NO20075194A NO20075194L NO 20075194 L NO20075194 L NO 20075194L NO 20075194 A NO20075194 A NO 20075194A NO 20075194 A NO20075194 A NO 20075194A NO 20075194 L NO20075194 L NO 20075194L
Authority
NO
Norway
Prior art keywords
hpv
vaccine
protein
immunogenic fragment
vaccines
Prior art date
Application number
NO20075194A
Other languages
English (en)
Inventor
Brigitte Desiree Alberte Colau
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36992675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20075194(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0509010A external-priority patent/GB0509010D0/en
Priority claimed from PCT/EP2005/006461 external-priority patent/WO2005123125A1/en
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of NO20075194L publication Critical patent/NO20075194L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]

Abstract

En fremgangsmåte for forebygging av HPV-infeksjon og/eller sykdom, hvor fremgangsmåten omfatter å levere en første HPV-vaksine omfattende et L1-protein eller immunogent fragment derav fra minst HPV 16 og HPV 18, og en andre HPV-vaksine som ikke omfatter HPV 16 og HPV 18 L1-komponentene fra den første vaksinen, og hvilken andre vaksine omfatter et L1-protein eller immunogent fragment derav fra minst én annen onkogen HPV-type, hvori de første og andre vaksinene kan leveres i hvilken som helst rekkefølge og levering er atskilt av et passende tidsintervall.
NO20075194A 2005-04-26 2007-10-11 vaksine NO20075194L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US67482905P 2005-04-26 2005-04-26
GB0509010A GB0509010D0 (en) 2005-05-03 2005-05-03 Vaccine
PCT/EP2005/006461 WO2005123125A1 (en) 2004-06-16 2005-06-14 Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52
PCT/EP2006/003918 WO2006114312A2 (en) 2005-04-26 2006-04-24 Vaccine

Publications (1)

Publication Number Publication Date
NO20075194L true NO20075194L (no) 2008-01-18

Family

ID=36992675

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075194A NO20075194L (no) 2005-04-26 2007-10-11 vaksine

Country Status (12)

Country Link
US (1) US20090181052A1 (no)
EP (1) EP1877086A2 (no)
JP (1) JP2008539184A (no)
KR (1) KR20080005585A (no)
AR (1) AR054259A1 (no)
AU (1) AU2006239422A1 (no)
CA (1) CA2606092A1 (no)
EA (1) EA013326B1 (no)
MX (1) MX2007013472A (no)
NO (1) NO20075194L (no)
SG (1) SG159525A1 (no)
WO (1) WO2006114312A2 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
ES2519490T3 (es) * 2008-07-31 2014-11-07 Glaxosmithkline Biologicals S.A. Vacuna contra HPV
BRPI0924981B1 (pt) * 2009-06-19 2022-02-08 Eyegene Inc Composição de vacina para câncer cervical
RU2610174C2 (ru) 2011-06-24 2017-02-08 Мерк Шарп И Доум Корп. Вакцинные составы против вируса папилломы человека (hpv), содержащие алюминиевый адъювант, и способы их получения
JP2023516904A (ja) 2020-02-14 2023-04-21 メルク・シャープ・アンド・ドーム・エルエルシー Ｈｐｖワクチン
WO2023014853A1 (en) 2021-08-06 2023-02-09 Merck Sharp & Dohme Llc Hpv vaccine
WO2023023152A1 (en) 2021-08-19 2023-02-23 Merck Sharp & Dohme Llc Thermostable lipid nanoparticle and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
GB9921147D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
US6908613B2 (en) * 2000-06-21 2005-06-21 Medimmune, Inc. Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
GB0105606D0 (en) * 2001-03-07 2001-04-25 Cantab Pharmaceuticals Res Ltd Immunogens and vaccines and their preparation and use
GB0206360D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
EA200701633A1 (ru) * 2002-12-20 2007-12-28 Глаксосмитклайн Байолоджикалс С.А. Вакцина на основе вирусоподобных частиц вируса папилломы человека 16 и вируса папилломы человека 18 l1
MY140664A (en) * 2003-09-29 2010-01-15 Merck Sharp & Dohme Optimized expression of hpv 45 l1 in yeast

Also Published As

Publication number Publication date
EP1877086A2 (en) 2008-01-16
US20090181052A1 (en) 2009-07-16
KR20080005585A (ko) 2008-01-14
WO2006114312A2 (en) 2006-11-02
CA2606092A1 (en) 2006-11-02
SG159525A1 (en) 2010-03-30
MX2007013472A (es) 2008-04-02
EA200702079A1 (ru) 2008-04-28
AR054259A1 (es) 2007-06-13
JP2008539184A (ja) 2008-11-13
WO2006114312A3 (en) 2007-04-05
EA013326B1 (ru) 2010-04-30
AU2006239422A1 (en) 2006-11-02

Similar Documents

Publication Publication Date Title
NO20075194L (no) vaksine
MX2009004223A (es) Protocolo de inmunizacion contra los 4 serotipos del dengue.
MX2009003417A (es) Metodo de inmunizacion contra los 4 serotipos de dengue.
MY169275A (en) Method of immunization against the four serotypes of dengue
NZ529881A (en) Capsular polysaccharide solubilisation and combination vaccines
DK1296711T3 (da) HPV-E7 til behandling af humant papillomavirus
CL2008002559A1 (es) Construccion que comprende un vector de fluorocarbono y un antigeno del virus de la influenza; composicion farmaceutica que lo comprende; y su uso para aumentar la respuesta inmunologica
WO2007117303A3 (en) Combination vaccine comprising an attenuated bovine viral diarrhea virus
WO2006065553A3 (en) Glycoconjugate vaccines containing peptidoglycan
WO2009060281A3 (en) Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
WO2007002470A3 (en) Inactivated chimeric vaccines and related methods of use
DE60331412D1 (de) Hiv-vakzine und anwendungsverfahren
WO2006041978A3 (en) Multivalent avian influenza vaccines
SE9904581D0 (sv) A novel helicobacter pylori-binding substance and use thereof
NO20070195L (no) Vaksine mot HPV16 og HPV18 og minst en annen HPV-type valgt fra HPV31, 45 eller 52
NO20090290L (no) Polyvalent vaksine mot salmonid alfavirusinfeksjoner
NO20071030L (no) Immunogene komplekser, metoder for fremstilling derav og bruk av samme i farmasoytiske sammensetninger.
EA201170264A1 (ru) Вакцина против hpv
MXPA03009763A (es) Vacuna contra el virus de la enfermedad de la fiebre aftosa.
MXPA02003328A (es) Vacuna.
RU2008144180A (ru) Вакцина против микоплазмы и prrsv
WO2001022994A3 (en) Vaccines against neisseria infection
EP1532279A4 (en) METHOD, COMPOSITION AND ANTIGEN BINDING KIT OF NORWALK VIRUS
NZ591738A (en) Non-typhoidal salmonella vaccines comprising a polypeptide which is an outer membrane protein d of non typoidal salmonella
TW200716170A (en) Vaccine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application